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C1q TNF Related Protein 3 (CTRP3), is a cytokine that is primarily secreted from 
adipose tissue, which classifies it as an adipokine. Our previous research has shown that CTRP3 
prevents alcoholic fatty liver disease (ALD) in male mice. However, even when accounting for 
confounding factors such as absolute and relative alcohol intake, females are more sensitive to the 
effects of consumption compared to male mice. Therefore, the goal of this project was to determine 
whether CTRP3 prevented ALD in female mice. Methods: Female wild type (WT) and female 
CTRP3 transgenic over expressing (Tg) mice were fed an ethanol containing liquid diet (5% v/v) 
for 6 weeks. Daily weight and food intake measurements were taken and external heat-pads were 
placed under a portion of the cage to facilitate thermoregulation. Hepatic steatosis was determined 
by total triglyceride quantification and lipid droplet quantitation in liver sections. Data were 
analyzed by repeated measures ANOVA, t-test, or Log-rank (Mantel-Cox) test as appropriate. 
Results: There was no difference between WT and Tg mice in food intake or body weight. There 
was no difference in survival between WT and Tg mice, however, Tg mice trended towards a 
reduced rate of survival compared with WT mice (78% in WT versus 44% in Tg, p=0.13). 
Stereological analysis indicated no difference in the percent of lipid liver volume between the two 
groups (WT 7.2±3.6 vs Tg 5.1±4.1%). This finding was consistent with no difference in total 
hepatic triglyceride accumulation observed between WT and Tg mice (12.7±4.4 vs. 13.1±6.8 mg 
triglycerides/gram liver protein). Conclusion: Combined these data indicate that unlike previous 
studies with male mice, CTRP3 is not protective against alcohol-induced hepatic steatosis in 
female mice. Combined, these data indicate that the adipokines such as CTRP3 contribute to 
physiology in a sex-specific manner. 
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INTRODUCTION / LITERATURE REVIEW 
 
The National Institute of Alcohol Abuse and Alcoholism defines moderate drinking 
levels as up to one drink a day for women and two drinks a day for men. In turn, it defines binge 
drinking as a pattern of alcohol consumption that brings the blood alcohol level to .08g/dL, with 
heavy alcohol use defined as repeating this pattern five of more days in a month. The 
combination of both of these tendencies can lead to an alcohol use  disorder and severe bodily 
effects such as Alcoholic Fatty Liver disease (ALD) (Drinking Levels Defined, n.d.) ALD can be 
defined as a multi-stage process characterized by the presence of hepatic lesions on the liver 
which can be identified as steatosis, hepatitis, and fibrosis/cirrhosis (in order of severity) (Osna, 
Donohue, & Kharbanda, 2017). Hepatic steatosis (fatty liver) is a point at which hepatic lesions 
accumulate on the liver and account for 5% of total liver weight with no signs yet of 
inflammation. In turn, hepatitis ensues when inflammation is present, and cirrhosis is a point at 
which fibrosis is detected (Sakhuja, 2014). Importantly, ALD has a large cultural impact that can 
have detrimental effects to one’s livelihood and lifestyle. Currently, there is no modern 
diagnostic tool to test the susceptibility to the development of ALD, and the pathogenies is still 
currently not completely understood (Gao & Bataller, 2011). More importantly, what makes this 
research relevant is the fact that there is currently no FDA-approved treatment on the market. As 
of now, the most effective treatment is seen as the cessation of drinking, and liver transplant if 
the disease progresses to a state as to where liver function is inadequate to support bodily 
function (Osna, Donohue, & Kharbanda, 2017). Another reason for interest in the topic is due to 
the fact that it has already been shown that there are noticeable differences between severity and 
presence of ALD between male and females. For example, women are more susceptible to 
alcohol-related liver damage than men, and women achieve higher blood alcohol content levels 
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as compared to men after drinking equivalent amounts of alcohol (Mumenthaler, Taylor, O'Hara, 
& Yesavage, 1999). In regard to mice specifically, it has been found that females have a higher 
mortality rate in response to chronic alcohol fed male mice (Trogen, et al., 2018). Because of 
this, we are interested to learn about the different mechanisms and factors that play into presence 
of and protection from ALD, and how we could possibly use these to make strides in decreasing 
the severity of the effects, or ultimately formulating a cure. 
The liver is a vital organ for bodily function as one of its main goals is to act as a filter 
for blood that is going through the digestive tract.  Likewise, it produces bile and other 
phospholipids (Knell, 1980). Although early stages of liver damage are asymptomatic, as the 
disease progresses ALD can not only affect the liver itself, but begin to show negative effects in 
other bodily functions. For the sake of this particular research we are specifically interested in 
the effect of excess alcohol consumption and ALD on adipose tissue. Adipose tissue plays an 
important role in storing excess fat in adipocytes while also acting as an active endocrine organ 
that can excrete both hormones and cytokines (Lundbom, 2017). Adipose tissue can be affected 
by alcohol in a multitude of different ways including both the mass of adipokines and adipokine 
secretion (Kema, Mojerla, Khan, & Mandal, 2015). Adipokines are secreted from adipose tissue 
and can have various effects throughout the body. These can be seen in instances such as their 
implications in insulin sensitivity, alterations of metabolic regulation and other homeostatic 
imbalances (Deng & Scherer, 2010). Adipokines come in many different specified forms that 
have been named and identified in accordance to their function and roles within body systems 
and placed into groups such as hormones, growth factors, angiogenic factors and cytokines 
(Pereira & Alvarez-Leite , 2013). For our research, we were particularly interested in the effect 
of alcohol on members of the C1q tumor necrosis factor (TNF)- related protein (the CTRP) 
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family. These adipokines present themselves to have a wide range of bodily impacts or areas 
functions such as metabolism, inflammation, and survival signaling in multiple tissue types (Li, 
Wright, & Peterson, 2017).  
C1q/TNF-Related Protein 3 (CTRP3) is a particularly significant secreted adipokine that 
has many different implications throughout the body. As it has been the center of many past 
studies, it has been found to be associated with factors such as triglyceride levels, glucose 
regulation and insulin sensitivity (Trogen, Alamian & Peterson, 2019). Further, it has been 
shown to increase adipokine secretion, attenuate inflammatory signaling, promote proliferation, 
increase cellular differentiation and increase hepatic lipid oxidation (Li, Wright, & Peterson, 
2017). Another interesting characteristic of CTRP3 is its tendency to demonstrate sex specific 
regulation and function (DeGroat A. R., et al., 2018). CTRP3 has been tied to similar liver 
dysfunction as seen in Non Alcoholic Fatty Liver disease (NAFLD) as it has shown to be 
protective against hepatic steatosis (Peterson, Seldin, & Wong, 2013). Studies looking at 
Nonalcoholic fatty liver disease show that CTRP3 levels are reduced in human patients who have 
been diagnosed with NAFLD, signaling the possibility of CTRP3 playing a protective role in 
NAFLD prevention (Peterson, Seldin, & Wong, 2013). Because of this correlation between 
CTRP3 and its attenuation of fatty liver disease, experimentation has begun to see if a correlation 
can also be found with the development and progression of ALD (DeGroat A. R., et al., 2018).  
In regard to CTRP3 and ALD specifically, there is relevant research that demonstrates the 
basis of interest between the correlation of the two, and the differences in severity and presence 
of ALD based on factors such as sex. Primarily, CTRP3 has been shown to act protectively 
against long term alcohol-induced lipid accumulation. This leads to the hypothesis that, 
combined with cessation of alcohol consumption, CTRP3 can be beneficial in treating ALD 
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(DeGroat A. R., et al., 2018). Because of this initial question, a publication entitled “The Sex 
specific effect of alcohol consumption on circulating levels of CTRP3” (DeGroat A. R., et al., 
2018) provides an extensive look at the effect of alcohol consumption on circulating adipokine 
levels (with CTRP3 being the main focus). Wildtype C57Bl6 mice were exposed to two different 
ethanol containing diets. One diet mimicked both chronic combined with binge feeding (NIAAA 
model), and the other a chronic with no binging component (chronic model) (Bertola, Mathews, 
Ki, Wang, & Gao, 2013). Utilizing these feeding models, the sex differentiating effects of 
CTRP3 can be exemplified by analyzing the adipokine levels and mortality rates. Likewise, it 
displayed that the effects of the chosen feeding models and adipokines vary as well. This 
research provided us with data that there is indeed a difference between adipokine expression in 
male and female mice. Mortality rate differences showed that females suffered approximately 
50% mortality during the 6-week alcohol feeding study, while in males, there was a no 
difference in mortality between control and ethanol fed mice (DeGroat A. R., et al., 2018). This 
shows the sex specific effects of an alcohol containing diet. Further, circulating CTRP3 levels in 
females decreased by ~75% in the NIAA model and ~50% in the chronic model while no 
changes were observed in males (DeGroat A. R., et al., 2018). Because CTRP3 levels have been 
shown to be selectively reduced in ethanol (ETOH) fed females, this could serve as a possible 
mechanism for the increased susceptibility of females to alcoholic cirrhosis (DeGroat A. , et al., 
2018).  
While this data was focused mainly on CTRP3, other adipokines were examined as well. 
Circulating adiponectin, determined by immunoblot, show that levels increase in both the 
NIAAA and chronic feeding models in females, and increased in males only in the chronic 
model (DeGroat A. R., et al., 2018). Adiponectin is a peptide that is secreted by adipocytes and 
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has been shown to play a role in insulin resistance, type 2 diabetes, and cardiovascular disease 
(Acharie & Jain, 2017). Adiponectin is related to ALD in particular because increased 
adiponectin levels have previously been correlated to patients with cirrhosis (Gamberi, 
Maherinie, Modesti, & Fiashi, 2018). With adiponectin it is important to note the effect of 
chronic alcohol abuse demonstrating a positive association between circulating adiponectin 
levels and the severity of liver damage (Tang, et al., 2012). It is interesting to note that even 
though both males and females show an increase in adiponectin concentration, females displayed 
a ~200% increase in circulating levels in the NIAAA model while males had no noticeable 
changes in circulating levels. In regard to the chronic diet, adiponectin levels doubled in both 
males and females (DeGroat A. R., et al., 2018). This data demonstrated the differing effects that 
both the feeding model type and sex can have on adiponectin levels. This data displayed an 
increase in both male and female mice that showed activating adiponectin mediated signaling 
pathways is not a particularly successful strategy for prevention/treatment of ALD due to levels 
already increasing with chronic ethanol exposure (DeGroat A. R., et al., 2018). The increase of 
adiponectin levels found in the NIAAA model female ETHOH fed mice may be used to account 
for the historic increased severity of ALD in females. These findings, along with many other 
notable discoveries that were made in the manuscript exemplify the sex differences in actions of 
adipokines and ALD. This can lead to further studies to examine the relationship between 
adipokines and ALD more in depth as well as CTRP3 as a potential mechanism for the increased 
susceptibility of females to ALD.  
With this knowledge that there is a correlation between CTRP3 and ALD, further study 
was warranted to see if overexpression of CTRP3 can prevent ALD (Trogen, et al., 2018). In a 
publication entitled, “Transgenic overexpression of CTRP3 prevents alcohol-induced hepatic 
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triglyceride accumulation” (Trogen, et al., 2018) the exploration of this possible intervention 
method is made through the use of WT and Tg+ CTRP3 overexpressed mice. Similarly, the 
NIAAA (used to mimic the hepatic steatosis and liver injury and inflammation that occur in 
many alcoholic hepatitis patients) and chronic fed model were employed identically to the 
previous study (Bertola, Mathews, Ki, Wang, & Gao, 2013). The primary findings showed that 
the overexpression of CTRP3 reduced triglyceride accumulation in the 6-week ethanol feeding, 
but not the NIAAA model (Trogen, et al., 2018) Because of the previously formulated thesis of 
CTRP3 attenuating alcohol-induced hepatic lipid accumulation, the study expected to see a 
protection of livers in the Tg-ETOH mice. But, there was no statistically significant protection 
observed in the NIAAA model (Trogen, et al., 2018).  
However, transgenic overexpression of CTRP3 completely abolished ethanol-induced 
hepatic steatosis in response to chronic ethanol feeding, including reversing the ethanol-induced 
changes to the hepatic fatty acid profile (Trogen, et al., 2018). These finding indicate that 
increased circulating levels of CTRP3 can act protectively over time in male mice (Trogen, et al., 
2018). The discrepancy between the two feeding models are thought to be due to the fact that 
liver triglyceride accumulation (the variable concentrations that are being studied) in the NIAAA 
model may be secondary to hepatic inflammation, and that CTRP3 levels were not sufficient to 
improve the initial inflammation and triglyceride accumulation (Trogen, et al., 2018). The 
resulting data also indicated that CTRP3 attenuated the effects of alcohol consumption on fatty 
acid oxidation or fatty acid elongation and desaturation in male mice (Trogen, et al., 2018). To 
further explore this correlation between CTRP3 and attenuation of hepatic steatosis, the study 
examined the phosphorylation status (activity levels) of many key enzymes in the regulation of 
lipid metabolism. Notably, there was an observed decrease in ERK1/2 and AMPK 
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phosphorylation in the Tg-ETOH group compared to that of the WT-ETOH (Trogen, et al., 
2018). Factors such as Akt, ACC, DGAT2 and SREBP1 showed no change in phosphorylation 
indicating that CTRP3 did not activate these enzymes (Trogen, et al., 2018). This is relevant due 
to the previously indicated implications of treatments focused on the blocking of ERK1/2 are 
associated with alcohol-induced hepatic damage (Li, C. et al., 2017). But this warrants further 
study as there are many contradictory beliefs in regard to the role of phosphorylated ERK1/2 in 
relation to possibly increasing sensitivity and first-hit and second-hit ALD (Trogen, et al., 2018).  
In addition, AMPK levels were seen to be elevated in WT-ETOH male mice compared to 
that of the Tg-ETOH male mice, with no difference in the phosphorylation status of ACC 
(Trogen, et al., 2018). Importantly, even though the mechanism of the action of AMPK is still 
fully not known, the elevated AMPK levels supports our hypothesis that the overexpression of 
CTRP3 attenuates the rise in AMPK phosphorylation which leads to lower total triglyceride 
accumulation. Once again further studies are warranted to further understand the mechanism 
between ACC phosphorylation and AMPk stimulation and the effect this truly has on ALD 
(Trogen, et al., 2018). The effects of CTRP3 in isolated hepatocytes was examined to see if 
CTRP3 over expression stimulates fatty acid oxidation (Trogen, et al., 2018). This is relevant due 
to the role of NADH promoting steatosis by stimulating the synthesis of fatty acids, in turn 
opposing their oxidation (Lieber, 2004). The collected data indicated that CTRP3 does not 
increase basal metabolism and CTRP3 (with added palmitic acid) increased oxygen 
consumption. Together, this data displays that CTRP3 stimulates lipid metabolism in the liver 
(Trogen, et al., 2018).  
An important limitation of the study above is that due to budgetary restrictions, only male 
mice were used in the study (Trogen, et al., 2018). In fact, this is a trend often replicated across 
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many fields of scientific research in regard to both mice and humans. Historically, fewer women 
are included in research, and results are often not reported by sex (Mazure & Jones, 2015). This 
is done because of the idea that female animal subjects will increase cost and study variability. 
But in reality, this variability is necessary due to the varying cross-sex differences evident in 
medicine and disease (Fields, 2014). Due to the previous research displaying that females are 
historically more susceptible to ALD, further studies should place focus on whether or not 
female mice under similar conditions would express the same results (Bellentani, et al., 1997). 
This in addition to the previously established notable sex differentiation upon cytokines, 
mortality, and ETOH feeding models, provides a reason to further explore the effect of cytokines 
on females  (DeGroat A. R., et al., 2018). This is the basis for our hypothesis and reasoning for 
replicating the previously mentioned “Transgenic overexpression of CTRP3 prevents alcohol-
induced hepatic triglyceride accumulation” study to include a Tg+ CTRP3 overexpressing 
female mice group compared to that of a WT-ETOH fed female group. We hypothesize that the 
data will display that CTRP3 acts protectively in females against ALD, but to a lesser extent to 
account for the increased severity and progression of ALD in females versus males.  
  
   
 





Animal Model  
 
The CTRP3 transgenic overexpression (Tg) mouse strain was developed on the C5BI/6J 
background with the carboxy-terminal FLAG epitope (DYKDDDDK)-tagged CTRP3 expression 
driven by the CMV early enhance/chicken β-actin (CAG) promoter as described in (Peterson, 
Seldin, & Wong, 2013). Female mice were housed in polycarbonate cages on a 12-hour 
light/dark photocycle with ab libitum access to food and water, except as specified. Controls for 
this experiment were Wildtype (WT) littermates. Mice were inspected and weighed daily. At the 
time points indicated, animals were anesthetized with isoflurane and euthanized via 
exsanguination. Serum samples were prepared according to the manufacturer’s instructions 
(Sarstedt, cat. No. 41.1500.005). Tissue samples were excised, snap-frozen in liquid nitrogen 
(unless otherwise indicated), and stored at -80°C until further analysis. All animal procedures 
were conducted in accordance with institutional guidelines, and ethical approval was obtained 
from the University Committee on Animal Care (Animal Welfare Assurance no. A3203-01).  
Ethanol Feeding  
 
The chronic ethanol model was used in which 12-wk-old female mice were acclimatized 
to a liquid diet ad labium without the addition of alcohol for 1 wk then gradually transitioned 
from 1% to 5% ethanol (vol/vol ethanol) over a period of 2 weeks, then maintained at 5% for the 
remaining 4 wks. This feeding protocol is believed to reflect chronic ethanol abuse, beginning 
with low volumes and increasing over time (Breitkopf, et al., 2009) resulting in hepatic steatosis 
with only moderate inflammation (Bertola, Mathews, Ki, Wang, & Gao, 2013). On the morning 
of the final day, food was removed, and mice were fasted for 9 h before euthanasia. Following 
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euthanasia, tissue/serum samples were collected and processed for analysis. The 9 h time point 
was selected to be consistent with NIAAA model protocol. As opposed to the previous studies 
use of control group non-alcohol fed WT mice, the control group was identified as alcohol fed 
WT mice in order to properly explore the hypothesis of the sex specific benefits of CTRP3. This 
way, the protective abilities against ALD can be compared between the two alcohol fed cohorts. 
For this study, eighteen WT mice and ten CTRP3 Tg+ mice were used and all were ethanol fed.  
 
Liver Histology  
 
As briefly described by (Trogen, et al., 2018) a section of the lateral left lobe of the liver 
was fixed in 10% formalin for 2 days. Following fixation, the tissue was dehydrated and 
embedded in paraffin using standard embedding techniques. Each sample was sectioned at 5µm 
with a Microm HM325 microtome, mounted, and stained using standard hematoxylin and eosin 
(H&E) staining procedures. The tissue was examined and photographed using a Zeiss Axioskop 
40 microscope equipped with a Cannon powershot A640 camera.  
Immunoblot Analysis 
 As briefly described by (Trogen, et al., 2018) liver samples were pulverized in liquid 
nitrogen, and ~100 mg was suspended in radio immunoprecipitation assay (RIPA) buffer (50mM 
Tris−HCl, pH 8.0, 150 mM NaCl, .1% Triton X-100, .5% sodium doxycholate, .1% SDS) with 
protease and phosphatase inhibitors (Bimake, cat. Nos. B14001 and B15001). The samples were 
incubated for 30 min at 4°C with gentle rotation and then centrifuged at 16,000 g for 10 min at 
4°C. The supernatant containing the soluble fraction was collected and prepared for protein 
quantification. Protein concentrations were determined by commercial assay according to the 
manufacturer’s directions (Thermo, cat. no. 23238). Samples were diluted to equal protein 
concentrations with RIPA buffer and denatured at 95°C for 5 min after the addition of equal parts 
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2 x SDS loading buffer (4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 0.004% bromophenal 
blue, 0.125 M Tris·HCl, Ph 6.8), followed by cooling for 5 min on ice. Denatured proteins were 
separated by SDS-polyacrylamide gel electrophoresis, according to the manufacturer’s directions 
(Bio-Rad, cat. no. 456-1046), with the addition of a protein ladder (Bio-Rad, cat. no. 161-0374). 
After gel electrophoresis, proteins were transferred to a nitrocellulose membrane according to 
standard procedures (Bio-Rad, cat. no. 1620115). Equal loading was confirmed by Ponceau S 
stain (0.1% Ponceau S, 5% acetic acid). Membranes were blocked with 4% nonfat milk solution 
for 1 h at room temperature and then probed with primary antibody (Cell-Signaling Technology 
cat no. 9102) overnight at 4°C, followed by appropriate horseradish peroxidase (HRP)-
conjugated secondary antibody (Thermo Fisher Scientific cat no. 3146). Chemiluminescent 
signals were detected (chemiluminescent HRP substrate, Millipore, cat. no. 
WBKLS0100) with a Bio-rad imager, and band intensities were measured densitometrically and 
expressed as fold changes relative to those of normal control livers.  
 
Hepatic lipid analysis   
  Lipids were extracted as described by Bligh and Dyer and as previously 
performed (6, 26). Briefly, liver samples were weighed and homogenized in phosphate-buffered 
saline (10 ml/g tissue), followed by the addition of 1:2 (vol/vol) chloroform-methanol (3.75 
ml/ml sample homogenate). Next, chloroform was added (1.2 ml/ml sample homogenate), 
followed by a final addition of distilled water (1.25 ml/ml sample homogenate). Samples were 
vortexed for 30 s between each step. Samples were then centrifuged (1,100 g for 10 min at room 
temperature) for phase separation (aqueous phase on top and organic phase below). The lower 
phase was collected with a glass pipette with gentle positive pressure (so as not to disturb the 
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upper phase). Samples were then divided into two aliquots and dried under nitrogen gas at 60°C. 
To measure total triglyceride levels, one aliquot from each sample was dissolved in tert-butyl 
Alcohol-Triton X-100 (3:2 vol/vol) solution. Triglycerides were quantified via colorimetric assay 






   
 





Animal Characteristics  
 
 As consistent with past studies utilizing the chronic feeding protocol, there was no 
statistical difference between the food intake levels of the WT and CTRP3 Tg+ cohorts (Figure 1 
A), as well as no difference between body weight, even when normalized in regard to food intake 
(Figure 1 B-C). Unexpectedly, there was no statistical difference between the survival proportions 
in regard to the WT and Tg+ groups. In fact, the Tg+ cohort trended towards a decreased rate of 
survival in comparison to that of the WT mice (78% in WT versus 44% in Tg, p=0.13).  
 
 
Figure 1. Animal Characteristics   
Transgenic overexpression of C1q tumor necrosis factor-related protein 3 (CTRP3 Tg) in female mice had 
no effect upon the food intake (A) or body weight (B) when compared to Wildtype (WT) female mice. 
Daily body weights were also averaged over the week time period for each mouse and normalized to week 
0 (C). Between WT and Tg+ female mice in a chronic fed model, there was no significant difference in 
survival, however, Tg female mice trended (p=0.07) towards a reduced rate of survival compared to WT 
female mice (D). Data are reported as means ± SD.  
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Lipid Quantification  
 
 In order to measure the degree of severity of liver steatosis (fatty liver) present in WT vs 
Tg+ female mice, a qualitative and quantitative analysis of hepatic lipid accumulation was 
performed. Unexpectedly, a representative qualitative analysis of the WT and Tg+ left lobe liver 
imaging (figure 2-C), displays no noticeable differences between the hepatic lipid accumulation levels 
of the two experimental groups. In support of this finding, Stereological analysis (figure 2-A) indicated no 
difference in the percent of lipid liver volume between the two groups (WT 7.2±3.6 vs Tg 5.1±4.1%). 
Similarly, figure 2-B indicate no difference in the percent of lipid liver volume between the WT and 
Tg+ mice.  
  
Figure 2. Hepatic lipid content.  A) Total hepatic lipid content as a percent area was determined in 
ethanol fed wild type (WT) and CTRP3 transgenic female mice (Tg+) female mice. B) Total hepatic 
triglycerides quantification in WT vs Tg+ female mice. C) Representative hematoxylin and eosin-stained 





   
 
  19 
 
Circulating Serum Analytes  
 
 In order to measure the impact of ethanol on inflammation and metabolics, several 
precursor pro-inflammatory serum analytes concentration levels were examined and compared 
between the WT and Tg+ mice. Interestingly, the data in figure 3 displays no statistically 
significant difference in TNF-α (Figure 1-A) Interleukin 6 (IL-6) (Figure 1-B), Interleukin 1β 
(IL-1β) (Figure 1-C), Interleukin 10 (IL-10) (Figure 1-D), Interleukin 17 alpha (IL-17alpha) 
(Figure 1-E), and Interferon gamma (IFN-g) (Figure 1-F) levels. This is indicative of a lack of 





















Figure 3. Effects of transgenic overexpression of CTRP3 and chronic ethanol diet on the 
concentration of circulating serum cytokines.  
Concentration of Tumor Necrosis Factor – alpha (TNF-α) (A), Interleukin 6 (IL-6)(B), Interleukin 
1-Beta (IL-1β), Interleukin 10 (IL-10) (D), Interleukin 17 alpha (IL-17alpha) (E), Interferon-
gamma (IFN-g) (F) in chronic fed Transgenic overexpressed C1q tumor necrosis factor-related 
protein 3 (CTRP3 Tg) and Wildtype (WT) female mice. Measurements taken in pictograms per 
milliliter. Data are reported as means ± SD.  
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Circulating ERK 1/2  
 
The concentration levels of ERK ½ (extracellular signal-regulated kinases 1/2) was 
measured due to its role as a signaling protein of CTRP3, and its proposed role in alcohol 
induced hepatic damage. Immunoblot assays performed on Bio-Rad Chemidoc technology were 
utilized to examine optical density and in turn, concentration levels of circulating signaling 
protein levels. Unexpectedly, as seen in Figure 5, the data displays a slightly higher ERK 1/2 
concentration in the Tg+ female mice, which is directly opposite of what was observed in the 
Tg+ male mice data previously studied. Because of studies involved with the treatment models 
focusing on blockage of ERK 1/2 resulting in reduced alcohol induced hepatic damage, we 
would expect to see that if CTRP3 was indeed protective, we would also see reduced ERK ½ 
levels.  
 
Figure 5. Effect of Transgenic Overexpression of CTRP3 and Chronic Ethanol diet on 
hepatic phosphorylation of ERK 1/2.  
Hepatic ERK ½ total and phosphorylated proteins levels were measured in chronic ethanol fed wild type 
(WT) and CTRP3 transgenic female mice (Tg+). Data reported as optical density of phosphorylated 
normalized to total protein. Data are reported as means ± SD.  
  
   
 




The purpose of this study was to determine whether CTRP3 prevented ALD in female 
mice. Unexpectedly, our findings led us to conclude that CTRP3 does not act protectively in 
female CTRP3 Tg+ mice, which is in direct contradiction as to what is seen in the previously 
studied CTRP3 Tg+ male mice. When comparing these two studies, this difference displays the 
sex-dependent differentiation in the protective mechanism of CTRP3 and ALD. In accordance 
with past research, we hypothesized a lesser degree of protection in females to account for their 
historically higher quantity and severity of ALD cases. But the data shows a stark and drastic 
difference between WT and Tg+ female mice. This can lead to the notion that in females, CTRP3 
is acting in a non-protective fashion.  
Interestingly, the survival curve displays a non-significant difference between percent 
survival of WT and CTRP3 Tg+ female mice. Even further, the data trended towards a decreased 
survival percentage in CTRP3 Tg+ mice. This displays the lack of protection CTRP3 was 
hypothesized to provide against the progression to chronic stages of alcoholic liver disease. The 
survival curve is contrary to the previously observed trend in chronic male CTRP3 Tg+ mice, 
who showed a greater percent survival as compare to WT male chronic fed mice. Similarly, there 
was no visual differences between the representative hematoxylin and eosin-stained hepatic images 
taken in both the CTRP3 Tg+ and WT female mice. The similar lipid accumulation levels is further 
supported by the lack of statistically significant differences in the histological hepatic lipid 
between the WT and Tg+ female mice. The same trend can be displayed with the lack of 
statistical significance in hepatic triglyceride levels. Interestingly, this data trended towards a 
slightly higher triglyceride concentration in the Tg+ female mice as compared to the WT female 
mice. Since lipid accumulation is indicative of steatosis of the liver, if CTRP3 were to be 
protective in female mice as previously seen in the male mice, lipid accumulation levels would 
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be lowered in the Tg+ female mice.  
The data concerning serum analytes displayed no statistically significant changes in 
circulating TNF-α, IL-6, IL-1B, Il-10, Il-17, and IFN-g. As these analytes are indicative of 
inflammation, we expected to see a decrease concentration in CTRP3 Tg+ female mice. Lower 
levels of inflammation are associated with lessened severity of ALD as this is a characteristic of 
the progression of this disease. In comparison to previous WT/Tg+ male studies, similar various 
other pro-inflammatory analytes (insulin, glucagon, resistin, GIP, ghrelin etc..) in the male 
similarly displayed no statistical difference between the two groups. (Trogen, et al., 2018).  
Unexpectedly, ERK1/2 levels were shown to be slightly increased in the female Tg+ 
mice as opposed to female WT mice. This is significant due to past research involving novel 
treatments concerning blockage of ERK ½. The blockage of ERK 1/2 has been associated with 
reduced alcohol induced hepatic damage (Li, et al., 2017). Even though the mechanism of action 
in this trend is unknown, it is still important to note in relation to CTRP3’s protective abilities. If 
CTRP3 were shown to have be protective in female mice, we would expect the data to trend 
toward a decrease in ERK ½ concentration in the CTRP3 Tg+ levels in females as seen in 
CTRP3 Tg+ male mice. But instead, the opposite was observed.  
Limitations of this study include namely the COVID-19 pandemic that ensued at the end 
of data collection, largely including the conclusion of immunoblot analysis. As of March 23rd, 
2020 all institutional courses at East Tennessee State University were moved online and students 
were not allowed in research facilities. Due to this, immunoblot data including AKT, AMPK, 
ACC, and others were not able to be concluded and in turn were not able to be included in this 
manuscript. To expand upon this research, further analysis should be included of various other 
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analytes and cytokines to reach further conclusions upon the relationship between the sex 
specific benefits of CTRP3.  
Outside of the detrimental effects of COVID-19 to the research, limitations of the study 
also include the housing characteristics of this study. The female mice were housed in pairs 
during the ethanol feeding study (in accordance to protocol) in order to mitigate social stress. 
Because of this, we are unsure of the specific levels of diet consumption per mouse. As utilized 
by past studies in the same protocol, the diet consumption is split evenly between the two housed 
animals to account for food consumption levels.  
To further expand upon this study’s findings, that CTRP3’s protective qualities vary 
depending on sex, it is imperative to continue to explore these differences. There is a wide array 
of possible explanations to this disparity, such as sex specific differences in metabolism, 
hormones, or other processes. Likewise, an interesting direction for further study would be the 
diagnostic role that CTRP3 can play in ALD. As the early stages of ALD can be non-
symptomatic, looking at how CTRP3 levels can be indicative of ALD severity could be an 
interesting mechanism to correlate their levels to the progression of the disease.  
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CONCLUSION 
 The purpose of this study was to determine whether CTRP3 prevented ALD in female 
mice. However, the data generated did not support the hypothesis. Therefore, we find that 
overexpression of CTRP3 does not prevent ALD in female mice. In summary, this research 
displays sex specific qualities of CTRP3 in relation to ALD. CTRP3 protected male mice from 
ALD, but does not act in a protective manner in female mice. This study has important and far 
reaching implications as it further builds our knowledge of the sex specific abilities of CTRP3. 
As most research has primarily used male subjects, the findings of this project highlight the 
necessity of therapeutic and pharmaceutical studies to report on not only male responses but also 
on the responses of females.  
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